돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 22977458생성일: 2026년 10월 24일

(2S)-1-[(tert-butoxy)carbonyl]-4,4-difluoropyrrolidine-2-carboxylic acid

(S)-1-(tert-Butoxycarbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid · (S)-1-Boc-4,4-difluoropyrrolidine-2-carboxylic acid · EOS-60318 · )-4,4-difL · BOC-L-PRO(4,4-DIFLUORO) · Boc-4,4-difluoro-L-Pro-OH · BOC-4,4-DIFLUORO-L-PROLINE · (S)-1-(tert-ButoxycarbonyL

https://huagongshe.com/ko/chemical/22977458

(2S)-1-[(tert-butoxy)carbonyl]-4,4-difluoropyrrolidine-2-carboxylic acid 분자 구조식

식별자 및 물리적 특성

CAS No.203866-15-3
분자식C10H15F2NO4
평균 분자량251.23 g/mol
단동위원소 질량251.0969144 g/mol
SMILESCC(C)(C)OC(=O)N1CC(F)(F)C[C@H]1C(=O)O
InChIKeyWTMZYKCXBXPVPT-LURJTMIESA-N
PubChem CID22977458
EC No.633-844-9
DTXSIDDTXSID90629289

화학 및 물리적 성질

XLogP1.5
극성 표면적66.8
수소 결합 공여자 수1
수소 결합 수용자 수6
회전 가능 결합 수3
무거운 원자 수17
형식 전하0
복잡도338
녹는점120-124 °C
끓는 점340.4±42.0 °C(Predicted)
밀도1.31±0.1 g/cm3(Predicted)
저장 조건Keep in dark place,Sealed in dry,Room Temperature
pKa(산도 계수)3.06±0.40(Predicted)
물리적 상태powder to crystal
색상White to Light yellow to Light orange
InChIInChI=1S/C10H15F2NO4/c1-9(2,3)17-8(16)13-5-10(11,12)4-6(13)7(14)15/h6H,4-5H2,1-3H3,(H,14,15)/t6-/m0/s1
InChIKeyWTMZYKCXBXPVPT-LURJTMIESA-N
SMILESN1(C(OC(C)(C)C)=O)CC(F)(F)C[C@H]1C(O)=O

화학적 성질

solid

안전 및 규제

GHS 분류WarningH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 47 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesSkin Irrit. 2 (100%)
수질 위해 등급(WGK)3
관세 코드29339900
위험 문구(R)36/37/38
위험 표시Xi
안전 문구(S)26-36/37
위험 등급Eye Irrit. 2Skin Irrit. 2STOT SE 3
저장 분류11 - Combustible Solids

용도

용도

N-Boc-4,4-difluoro-L-proline is a reagent used in the preparation of structure-activity relationship and pharmacokinetics of pyrrolotriazines as pan-Aurora kinase inhibitors and anti tumor agents.